Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 36 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
Recruiting
A Study of Rocbrutinib in Combination With Lacutoclax in Patients With B-Cell Malignancies
NCT07609862
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +32 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, China
NCT07272499
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
Recruiting
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
NCT07121946
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Follicular Lymphoma ( FL), +18 more
- Locations
-
- City of Hope Duarte, California, United States
- Washington University School of Medicine St Louis, Missouri, United States
- Roswell Park Cancer Institute Buffalo, New York, United States
- Memorial Sloan Kettering Cancer Center - Bergen New York, United States
NCT07719556
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Changzhou Second People's Hospital Changzhou, Jiangsu, China
- Jiangsu province Hospital Nanjing, Jiangsu, China
Recruiting
Registry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic Neoplasms
NCT06043011
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +34 more
- Locations
-
- Praxis für Interdisziplinäre Hämatologie und Onkologie Freiburg im Breisgau, Germany
Recruiting
DALY II USA/ MB-CART2019.1 for DLBCL
NCT04792489
- Conditions
- Central Nervous System Lymphoma, Central Nervous System Neoplasms, Hemic and Lymphatic Diseases, +22 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Mayo Clinic Phoenix, Arizona, United States
- UC San Diego Health La Jolla, California, United States
NCT05098613
- Conditions
- B-cell Non-Hodgkin Lymphoma (B-NHL), CNS Lymphoma, Disease Attributes, +16 more
- Locations
-
- University of Colorado Hospital Aurora, Colorado, United States
NCT05131022
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +37 more
- Locations
-
- City of Hope Duarte, California, United States
- University of California, San Francisco San Francisco, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- Yale Cancer Center New Haven, Connecticut, United States
Recruiting
Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies
NCT06980116
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +38 more
- Locations
-
- LLC ARENSIA Exploratory Medicine Tbilisi, Georgia
- IMSP Institute of Oncology, ARENSIA Exploratory Medicine Chisinau, Moldova
- Hospital Beata Maria Ana Madrid, Spain
- Hospital Fundación Jiménez Diaz Madrid, Spain
NCT04830137
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +36 more
- Locations
-
- City of Hope Duarte, California, United States
- University of California Irvine Orange, California, United States
- University of California San Francisco Medical Center San Francisco, California, United States
- Sarah Cannon Research Institute at Colorado Blood Cancer Institute Denver, Colorado, United States
NCT04186520
- Conditions
- Central Nervous System Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia (CLL), +28 more
- Locations
-
- Medical College of Wisconsin and Froedtert Hospital Milwaukee, Wisconsin, United States
Recruiting
Relmacabtagene Autoleucel Combined With Sintilimab for Relapsed/Refractory B-cell Lymphoma
NCT07077512
- Conditions
- Follicular Lymphoma ( FL), Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Sun Yat-sen Universitiy Cancer Center Guangzhou, China
- Fifth Affiliated Hospital of Guangzhou Medical University Guangzhou, China
- Guangzhou overseas Chinese hospital Guangzhou, China
NCT07285590
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Instituto Português de Oncologia de Lisboa Francisco Gentil Lisbon, Lisbon District, Portugal
- Unidade Local De Saude De Santa Maria E.P.E. Lisbon, Lisbon District, Portugal
- INSTITUT CATALÀ D'ONCOLOGIA (ICO). Hospital Germans Trias I Pujol. Badalona, Barcelona, Spain
- Hospital Universitari Vall d'Hebron Barcelona, Spain
NCT07257510
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Peking University Third Hospital Beijing, Beijing Municipality, China
NCT07199296
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Ruijin Hospital Shanghai, China
NCT06846489
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Sun yat-sen university cancer center, Sun yat-sen university Guangzhou, Guangdong, China
NCT06788652
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Center for International Blood and Marrow Transplant Research (CIBMTR) Milwaukee, Wisconsin, United States
NCT06464861
- Conditions
- Diffuse Large B Cell Lymphoma( DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- the Second Affiliated Hospital, College of Medicine, Zhejiang University Hangzhou, Zhejiang, China
NCT06593145
- Conditions
- Acute Lymphoblastic Leukemia (ALL), Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
- Locations
-
- Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego - Centralny Szpital Kliniczny Warsaw, Ul. Banacha 1a, Poland
- Uniwersyteckie Centrum Kliniczne Gdańskiego Uniwersytetu Medycznego - Katedra i Klinika Hematologii i Transplantologii Gdansk, Ul. Smoluchowskiego 17, Poland
NCT06496308
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Ruijin Hospital Shanghai, China